Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chermside
Clinical trial register · Australia

Clinical Trials in Chermside, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Boehringer Ingelheim8 AstraZeneca8 Novo Nordisk A/S3 Edwards Lifesciences3 Abbott Medical Devices3
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Chermside

80 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Camperdown, Chermside, Greenslopes, South Brisbane, Adelaide, Frankston, Murdoch, Nedlands
2026-12-16
Not yet open
Microbio Co Ltd
Observational
1,500
Chermside, Woolloongabba
2026-11
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Canberra, Camperdown, Wollongong, Chermside, Douglas, Milton, Rockhampton, Sippy Downs
2026-10-26
Recruiting
Boehringer Ingelheim
Phase 3
466
Camperdown, Sydney, Chermside, Murdoch
2026-09-17
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07562152Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Immuneering Corporation
Phase 3
510
Kingswood, Waratah, Chermside, Woolloongabba, Adelaide, Frankston East, Murdoch
2026-06-05
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Canberra, Liverpool, Chelmer, Chermside, Ipswich, Milton, Adelaide, Bedford Park
2026-05-11
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
St Leonards, Chermside, South Brisbane, Bedford Park
2026-05-06
Not yet open
The University of Queensland
Observational
200
Chermside
2026-05-01
Recruiting
Incyte Corporation
Phase 3
588
Macquarie Park, Chermside, Townsville, Woodville South, Melbourne, Richmond, Canberra, Perth
2026-04-09
Not yet open
University of Newcastle, Australia
Not applicable
300
New Lambton Heights, Chermside
2026-03-01
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
NCT07201922Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
80
Camperdown, Chermside, Melbourne
2026-02-10
Recruiting
Contineum Therapeutics
Phase 2
324
Camperdown, Westmead, Chermside, Greenslopes, Heidelberg, Melbourne, Midland, Spearwood
2026-01-08
Active, closed
Boehringer Ingelheim
Phase 2
81
Chermside, Clayton, Nedlands
2025-11-13
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
414
Camperdown, Sydney, Darlinghurst, Chermside, Heidelberg, Murdoch
2025-09-13
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Box Hill, Camperdown, Chermside, Elizabeth Vale, Frankston, Frenchs Forest, Heidelberg, Hobart
2025-09-08
Recruiting
Boston Scientific Corporation
Not applicable
1,616
Chermside, Clayton
2025-08-21
Recruiting
ELEVATE-HFpEF Clinical Study
NCT06678841Heart Failure With Preserved Ejection Fraction (HFpEF)
Medtronic Cardiac Rhythm and Heart Failure
Not applicable
700
Chermside, Melbourne
2025-07-09
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Adelaide, Bedford Park, Box Hill, Chermside, Darlinghurst, Joondalup, Liverpool, Westmead
2025-07-02
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Garran, Camperdown, North Ryde, Westmead, Chelmer, Chermside, Greenslopes, South Brisbane
2025-06-09
Recruiting
AbbVie
Phase 2
110
Blacktown, Lambton Heights, Brisbane, Chermside, Ballarat, Clayton, Nedlands
2025-05-28
Recruiting
Eikon Therapeutics
Phase 2/3
740
Wollongong, Chermside, Bedford Park, Box Hill, Frankston
2025-05-22
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
DrugsVinblastine·Methotrexate·Doxorubicin·Durvalumab
AstraZeneca
Phase 2
150
Chermside, Elizabeth Vale, Heidelberg, Hong Kong, Kogarah, Macquarie University, Murdoch, Port Macquarie
2025-05-15
Recruiting
World Health Research Inc.
Observational
290
St Leonards, Chermside, Spring Hill, Melbourne, Murdoch
2025-05-13
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
NCT06951217Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc.
Phase 2
340
Camperdown, Macquarie Park, Westmead, Brisbane, Woodville South, Melbourne, Chermside, Footscray
2025-04-17
Active, closed
ASCEND CSP IDE Study
NCT06830746Heart Failure, Ventricular Arrythmia
Abbott Medical Devices
Not applicable
414
Chermside, Woolloongabba, Adelaide, Clayton
2025-04-11
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Endometrioid Ovarian Cancer
DrugsTORL-1-23·Pegfilgrastim
TORL Biotherapeutics, LLC
Phase 2
230
Clayton, Blacktown, Chermside, Bedford Park, Perth
2024-11-20
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Garran, Camperdown, Westmead, Chermside, Adelaide, Heidelberg, Melbourne, Murdoch
2024-09-26
Active, closed
Tectonic Therapeutic
Phase 2
191
Camperdown, Macquarie, New Lambton, Sydney, Wollongong, Chermside, Hobart, Malvern
2024-09-04
Recruiting
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2
69
Garran, Albury, Darlinghurst, St Leonards, Wahroonga, Chermside, South Brisbane, Adelaide
2024-08-14
Recruiting
AstraZeneca
Phase 3
620
Chermside, Clayton, Concord, Nedlands
2024-08-12
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Carlton, Chermside, Darlinghurst, Ivanhoe, Kogarah, Macquarie Park, Nedlands
2024-07-22
Active, closed
Sanofi
Phase 2
185
Chermside, South Brisbane, North Adelaide, Box Hill, Fitzroy, Frankston
2024-06-20
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Garran, Concord, Gosford, Kingswood, Kotara, Brisbane, Chermside, Tugun
2024-06-17
Active, closed
Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
NCT06125951Dementia Moderate, Dementia, Mild, Alzheimer Disease
Actinogen Medical
Phase 2/3
247
Darlinghurst, Erina, Kogarah, Macquarie Park, Newcastle, Birtinya, Chermside, Bedford Park
2024-04-12
Recruiting
AstraZeneca
Phase 3
3,850
Blacktown, Cairns, Canberra, Chermside, Clayton, Concord, Frankston, Geelong
2024-04-12
Active, closed
Novo Nordisk A/S
Phase 3
673
Garran, New Lambton Heights, Wollongong, Brisbane, Chermside, Ballarat, Epping, Mulgrave
2024-04-01
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
740
Camperdown, Chermside, Clayton, Hobart, Hyde Park
2024-02-26
Recruiting
AstraZeneca
Phase 3
5,250
Birtinya, Cairns, Chermside, Coffs Harbour, Dubbo, Nedlands, Port Macquarie, Spearwood
2024-02-21
Active, closed
Melanoma and Skin Cancer Trials Limited
Phase 3
146
Camperdown, Westmead, Chermside, Woolloongabba, Carlton, Melbourne
2024-02-09
Active, closed
Bristol-Myers Squibb
Phase 4
63
Camperdown, Chermside, Melbourne
2024-01-24
Active, closed
AstraZeneca
Phase 3
1,898
Chermside, Darlinghurst, Hyde Park, Kurralta Park, Melbourne, South Brisbane
2023-11-21
Active, closed
AstraZeneca
Phase 3
863
Chermside, Clayton, Melbourne, Nedlands, Westmead
2023-11-09
Recruiting
United Therapeutics
Phase 3
698
Camperdown, Kogarah, Brisbane, Chermside, Box Hill, Clayton, Heidelberg, Midland
2023-10-30
Active, closed
VOLT CE Mark Study
NCT06106594Atrial Arrhythmia, Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
Abbott Medical Devices
Not applicable
300
Chermside, Adelaide, Clayton, Parkville
2023-10-24
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Concord, Darlinghurst, Macquarie University, North Ryde, Randwick, Brisbane, Chermside, Herston
2023-09-22
Active, closed
Boehringer Ingelheim
Phase 2
268
Macquarie Park, Westmead, Chermside, South Brisbane, Nedlands, Spearwood
2023-09-08
Active, closed
Cytokinetics
Phase 3
500
Chermside, Adelaide, Murdoch
2023-08-31
Recruiting
Stepcare Extended Follow-up Substudy
NCT06207942Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain, Cognitive Impairment, Caregiver Burden
Region Skane
Not applicable
600
Brisbane, Caringbah, Chermside, Kingswood, Kogarah, Liverpool, Melbourne, Sydney
2023-08-01
Active, closed
Advanced NanoTherapies
Not applicable
28
Chermside, Adelaide, Clayton
2023-01-30
Active, closed
Bellus Health Inc. - a GSK company
Phase 3
997
Coffs Harbour, Macquarie University, New Lambton Heights, St Leonards, Chermside, Adelaide, St Albans, Nedlands
2022-12-05
Active, closed
RESPONDER-HF Trial
NCT05425459Heart Failure, Heart Failure, Diastolic
Corvia Medical
Not applicable
750
Darlinghurst, New Lambton Heights, Chermside, Melbourne
2022-11-17
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Camperdown, Chermside, Melbourne, Nedlands, Parkville, South Brisbane, Westmead
2022-11-08
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Camperdown, Macquarie Park, Westmead, Cairns, Chermside, South Brisbane, Melbourne
2022-09-06
Active, closed
Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation
NCT05003609Extracorporeal Membrane Oxygenation Complication
Australian and New Zealand Intensive Care Research Centre
Not applicable
100
Camperdown, Darlinghurst, Chermside, Woolloongabba, Melbourne, Murdoch
2022-04-27
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2
310
Chermside, South Brisbane, Adelaide, Toorak Gardens, East Melbourne, Nedlands, Subiaco
2022-02-17
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Adelaide, Bedford Park, Campbelltown, Chermside, Clayton, Halls Creek, Heidelberg, Melbourne
2022-02-07
Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
NCT04889872Aortic Stenosis, Calcific, Aortic Valve Stenosis
Edwards Lifesciences
Not applicable
2,250
Chermside, Adelaide, Bedford Park, Clayton
2021-10-12
Active, closed
Pfizer
Phase 3
77
North Ryde, Wollstonecraft, Chermside
2021-09-29
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Adelaide, Ballarat, Chermside, Clayton, Concord, Epping, Garran, Gosford
2021-08-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Camperdown, Chermside, Darlinghurst, New Lambton Heights, Adelaide, Hobart, Murdoch
2021-05-12
By invitation
Cytokinetics
Phase 2/3
900
Bedford Park, Chermside, Murdoch
2021-05-06
Active, closed
The ENCIRCLE Trial
NCT04153292Mitral Regurgitation, Mitral Valve Insufficiency
Edwards Lifesciences
Not applicable
786
Chermside, Camperdown
2020-11-12
Active, closed
Exelixis
Phase 3
575
Garran, Port Macquarie, Saint Leonards, Sydney, Wollongong, Chermside, Launceston, Ballarat
2020-10-19
Active, closed
Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
NCT05524077Heart Disease Structural Disorder, Ventricular Tachycardia, Cardiomyopathy, Dilated, Sarcoidosis
Western Sydney Local Health District
Not applicable
162
Camperdown, Kingswood, New Lambton Heights, Saint Leonards, Westmead, Chermside, Southport, Adelaide
2020-07-08
Active, closed
Actelion
Phase 3
935
Bedford Park, Camperdown, Chermside, Darlinghurst, Hobart, Murdoch, Westmead
2020-06-30
Recruiting
University of Leicester
Not applicable
2,104
Garran, Liverpool, St Leonards, Westmead, Wollongong, Chermside, Douglas, Southport
2020-03-10
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Camperdown, Darlinghurst, Sydney, Chermside, Woolloongabba, Hobart, Fitzroy, Melbourne
2019-09-23
Active, closed
Applied Therapeutics, Inc.
Phase 3
675
Chermside, Milton, Taringa, Hobart, Geelong, Heidelberg, Melbourne
2019-09-20
Active, closed
AstraZeneca
Phase 3
587
Camperdown, Chermside, Elizabeth Vale, Heidelberg, Kogarah, Melbourne
2019-07-02
Active, closed
PARTNER 3 Trial - Mitral Valve in Valve
NCT03193801Mitral Valve Insufficiency, Mitral Valve Disease, Mitral Valve Regurgitation, Heart Failure
Edwards Lifesciences
Not applicable
53
Chermside
2018-02-01
Active, closed
EBR Systems, Inc.
Not applicable
300
Garran, New Lambton Heights, Randwick, Wahroonga, Chermside, Adelaide, Clayton, Parkville
2018-01-17
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Westmead, Chermside, Adelaide, Melbourne, Murdoch
2017-12-29
Active, closed
Pfizer
Phase 3
1,054
Camperdown, Darlinghurst, Port Macquarie, Auchenflower, Brisbane, Chermside, South Brisbane, Southport
2017-12-18
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
St Leonards, Chermside, Kurralta Park
2017-09-22
By invitation
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
NCT02796937Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
Grifols Therapeutics LLC
Phase 3
290
Darlinghurst, Adelaide, Chermside, Fitzroy, Nedlands
2016-07
Active, closed
Abbott Medical Devices
Not applicable
1,242
Sydney, Chermside, Adelaide, Melbourne, Murdoch
2014-05
Active, closed
AstraZeneca
Phase 3
510
Camperdown, Chermside, Darlinghurst, Fitzroy, Kogarah, Kurralta Park, Malvern, Wendouree
2013-09-25
Active, closed
MedImmune LLC
Phase 2
571
Adelaide, Auchenflower, Box Hill, Chermside, East Bentleigh, Gosford, Heidelberg, Nedlands
2013-05-17
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Westmead, Chermside, Murdoch, Southport
2012-01
Recruiting
Medtronic
Observational
20,000
Chermside, Douglas, Murdoch, Southport
1983-01
Rows per page Showing 1–80 of 80
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/chermside

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 80 of those studies with a site in Chermside.

How many clinical trials are recruiting in Chermside?

32 of the 80 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 5 have not yet opened recruitment, 38 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chermside), 80 studies
PhaseStudiesRecruitingShare
Phase 3401550%
Not applicable16520%
Phase 214817.5%
Observational536.3%
Phase 2/3415%
Phase 4101.3%

Most active sponsors

Lead sponsors with the most studies (Chermside)
Lead sponsorStudiesRecruiting
AstraZeneca84
Boehringer Ingelheim84
Abbott Medical Devices30
Edwards Lifesciences31
Novo Nordisk A/S31
United Therapeutics31
Bristol-Myers Squibb20
Cytokinetics20
Medtronic22
Pfizer20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.